SOSV portfolio company Metabolic Psychiatry Labs is helping redefine how we understand mental health.

Founder and CEO Dr. Shebani Sethi, a Stanford University researcher, studies the role of metabolic dysfunction in conditions like depression, schizophrenia, and other disorders. This week, she published a new peer-reviewed paper in Nature Mental Health and spoke to STAT News about the field of metabolic psychiatry.

This work is part of a broader shift now gaining momentum across science and medicine. Increasingly, researchers and clinicians are recognizing that metabolism plays a critical role in psychiatric illness.

At Metabolic Psychiatry Labs, that insight is being translated into action, bridging cutting-edge research with evidence-based clinical care to deliver new approaches for patients.